CINTAS CORP (CTAS) Fundamental Analysis & Valuation

NASDAQ:CTAS • US1729081059

199.75 USD
-0.37 (-0.18%)
Last: Mar 5, 2026, 10:49 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CTAS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

CTAS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 81 industry peers in the Commercial Services & Supplies industry. CTAS gets an excellent profitability rating and is at the same time showing great financial health properties. CTAS is valied quite expensively at the moment, while it does show a decent growth rate. This makes CTAS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

10

1. CTAS Profitability Analysis

1.1 Basic Checks

  • CTAS had positive earnings in the past year.
  • CTAS had a positive operating cash flow in the past year.
  • In the past 5 years CTAS has always been profitable.
  • In the past 5 years CTAS always reported a positive cash flow from operatings.
CTAS Yearly Net Income VS EBIT VS OCF VS FCFCTAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CTAS has a Return On Assets of 18.67%. This is amongst the best in the industry. CTAS outperforms 100.00% of its industry peers.
  • The Return On Equity of CTAS (42.46%) is better than 96.30% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 24.58%, CTAS belongs to the top of the industry, outperforming 98.77% of the companies in the same industry.
  • CTAS had an Average Return On Invested Capital over the past 3 years of 21.68%. This is significantly above the industry average of 10.49%.
  • The last Return On Invested Capital (24.58%) for CTAS is above the 3 year average (21.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROIC 24.58%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
CTAS Yearly ROA, ROE, ROICCTAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of CTAS (17.52%) is better than 97.53% of its industry peers.
  • In the last couple of years the Profit Margin of CTAS has grown nicely.
  • Looking at the Operating Margin, with a value of 22.98%, CTAS belongs to the top of the industry, outperforming 97.53% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CTAS has grown nicely.
  • CTAS has a better Gross Margin (50.25%) than 88.89% of its industry peers.
  • CTAS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
CTAS Yearly Profit, Operating, Gross MarginsCTAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CTAS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CTAS is creating value.
  • The number of shares outstanding for CTAS has been reduced compared to 1 year ago.
  • The number of shares outstanding for CTAS has been reduced compared to 5 years ago.
  • CTAS has a better debt/assets ratio than last year.
CTAS Yearly Shares OutstandingCTAS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CTAS Yearly Total Debt VS Total AssetsCTAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CTAS has an Altman-Z score of 12.22. This indicates that CTAS is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.22, CTAS belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
  • CTAS has a debt to FCF ratio of 1.67. This is a very positive value and a sign of high solvency as it would only need 1.67 years to pay back of all of its debts.
  • The Debt to FCF ratio of CTAS (1.67) is better than 85.19% of its industry peers.
  • CTAS has a Debt/Equity ratio of 0.54. This is a neutral value indicating CTAS is somewhat dependend on debt financing.
  • CTAS has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.
  • Although CTAS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Altman-Z 12.22
ROIC/WACC2.88
WACC8.54%
CTAS Yearly LT Debt VS Equity VS FCFCTAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that CTAS should not have too much problems paying its short term obligations.
  • CTAS has a Current ratio of 1.71. This is in the better half of the industry: CTAS outperforms 64.20% of its industry peers.
  • A Quick Ratio of 1.49 indicates that CTAS should not have too much problems paying its short term obligations.
  • The Quick ratio of CTAS (1.49) is better than 61.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.49
CTAS Yearly Current Assets VS Current LiabilitesCTAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CTAS Growth Analysis

3.1 Past

  • CTAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.63%, which is quite good.
  • Measured over the past years, CTAS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.84% on average per year.
  • The Revenue has grown by 8.60% in the past year. This is quite good.
  • CTAS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.85% yearly.
EPS 1Y (TTM)11.63%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%11.01%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%9.3%

3.2 Future

  • Based on estimates for the next years, CTAS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.23% on average per year.
  • CTAS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.20% yearly.
EPS Next Y12.72%
EPS Next 2Y11.86%
EPS Next 3Y11.45%
EPS Next 5Y11.23%
Revenue Next Year8.73%
Revenue Next 2Y8.07%
Revenue Next 3Y7.79%
Revenue Next 5Y8.2%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAS Yearly Revenue VS EstimatesCTAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
CTAS Yearly EPS VS EstimatesCTAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. CTAS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 43.14, CTAS can be considered very expensive at the moment.
  • CTAS's Price/Earnings is on the same level as the industry average.
  • CTAS is valuated expensively when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 36.20, the valuation of CTAS can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CTAS is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, CTAS is valued a bit more expensive.
Industry RankSector Rank
PE 43.14
Fwd PE 36.2
CTAS Price Earnings VS Forward Price EarningsCTAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CTAS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTAS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 44.86
EV/EBITDA 27.76
CTAS Per share dataCTAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of CTAS may justify a higher PE ratio.
PEG (NY)3.39
PEG (5Y)2.56
EPS Next 2Y11.86%
EPS Next 3Y11.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CTAS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.91%, CTAS is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.79, CTAS pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.91, CTAS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

  • On average, the dividend of CTAS grows each year by 18.49%, which is quite nice.
  • CTAS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CTAS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)18.49%
Div Incr Years3
Div Non Decr Years3
CTAS Yearly Dividends per shareCTAS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 34.69% of the earnings are spent on dividend by CTAS. This is a low number and sustainable payout ratio.
  • CTAS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.69%
EPS Next 2Y11.86%
EPS Next 3Y11.45%
CTAS Yearly Income VS Free CF VS DividendCTAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CTAS Dividend Payout.CTAS Dividend Payout, showing the Payout Ratio.CTAS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAS Fundamentals: All Metrics, Ratios and Statistics

CINTAS CORP

NASDAQ:CTAS (3/5/2026, 10:49:11 AM)

199.75

-0.37 (-0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)12-18
Earnings (Next)03-24
Inst Owners66.98%
Inst Owner Change0.32%
Ins Owners1.65%
Ins Owner Change-0.1%
Market Cap79.88B
Revenue(TTM)10.79B
Net Income(TTM)1.89B
Analysts71.43
Price Target223.36 (11.82%)
Short Float %2.05%
Short Ratio3.73
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend1.51
Dividend Growth(5Y)18.49%
DP34.69%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.88%
Min EPS beat(2)-0.91%
Max EPS beat(2)-0.85%
EPS beat(4)1
Avg EPS beat(4)0.77%
Min EPS beat(4)-0.91%
Max EPS beat(4)4.93%
EPS beat(8)5
Avg EPS beat(8)3.74%
EPS beat(12)8
Avg EPS beat(12)2.8%
EPS beat(16)12
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)0
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.57%
PT rev (1m)0.98%
PT rev (3m)0.01%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)0.44%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 43.14
Fwd PE 36.2
P/S 7.4
P/FCF 44.86
P/OCF 36.25
P/B 17.93
P/tB 118.49
EV/EBITDA 27.76
EPS(TTM)4.63
EY2.32%
EPS(NY)5.52
Fwd EY2.76%
FCF(TTM)4.45
FCFY2.23%
OCF(TTM)5.51
OCFY2.76%
SpS26.99
BVpS11.14
TBVpS1.69
PEG (NY)3.39
PEG (5Y)2.56
Graham Number34.07
Profitability
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROCE 30.79%
ROIC 24.58%
ROICexc 25.21%
ROICexgc 48.61%
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
FCFM 16.5%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
ROICexc(3y)22.42%
ROICexc(5y)21.1%
ROICexgc(3y)45.31%
ROICexgc(5y)44.66%
ROCE(3y)27.16%
ROCE(5y)25.44%
ROICexgc growth 3Y4.19%
ROICexgc growth 5Y9.87%
ROICexc growth 3Y7.31%
ROICexc growth 5Y10.45%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
F-Score8
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Debt/EBITDA 0.81
Cap/Depr 84.15%
Cap/Sales 3.92%
Interest Coverage 250
Cash Conversion 73.86%
Profit Quality 94.13%
Current Ratio 1.71
Quick Ratio 1.49
Altman-Z 12.22
F-Score8
WACC8.54%
ROIC/WACC2.88
Cap/Depr(3y)83.77%
Cap/Depr(5y)69.7%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.41%
Profit Quality(3y)98.91%
Profit Quality(5y)102.51%
High Growth Momentum
Growth
EPS 1Y (TTM)11.63%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%11.01%
EPS Next Y12.72%
EPS Next 2Y11.86%
EPS Next 3Y11.45%
EPS Next 5Y11.23%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%9.3%
Revenue Next Year8.73%
Revenue Next 2Y8.07%
Revenue Next 3Y7.79%
Revenue Next 5Y8.2%
EBIT growth 1Y11.71%
EBIT growth 3Y13.89%
EBIT growth 5Y14.4%
EBIT Next Year31.87%
EBIT Next 3Y15.86%
EBIT Next 5Y13.68%
FCF growth 1Y35.78%
FCF growth 3Y10.65%
FCF growth 5Y10.61%
OCF growth 1Y29.87%
OCF growth 3Y12.1%
OCF growth 5Y10.89%

CINTAS CORP / CTAS FAQ

Can you provide the ChartMill fundamental rating for CINTAS CORP?

ChartMill assigns a fundamental rating of 7 / 10 to CTAS.


What is the valuation status for CTAS stock?

ChartMill assigns a valuation rating of 2 / 10 to CINTAS CORP (CTAS). This can be considered as Overvalued.


Can you provide the profitability details for CINTAS CORP?

CINTAS CORP (CTAS) has a profitability rating of 10 / 10.


What is the financial health of CINTAS CORP (CTAS) stock?

The financial health rating of CINTAS CORP (CTAS) is 8 / 10.


Can you provide the dividend sustainability for CTAS stock?

The dividend rating of CINTAS CORP (CTAS) is 5 / 10 and the dividend payout ratio is 34.69%.